Explore our latest reports, analysis, research, and submissions to drug policy processes here.
- 
 Submission on Safer Municipalities Act, 2024 – Restricting Public Consumption of Illegal Substances Act, 2024Read more: Submission on Safer Municipalities Act, 2024 – Restricting Public Consumption of Illegal Substances Act, 2024In January 2025, CDPC made a submission to the Ontario government’s request for public comment… 
- 
 Getting to Tomorrow: 7 Actions to End the Unregulated Drug CrisisRead more: Getting to Tomorrow: 7 Actions to End the Unregulated Drug Crisis(Le français suite) [scribd id=800617809 key=key-uQYIlnFiMn4QozNAsyU1 mode=scroll] Download Final Report (EN) In fall 2020, the Canadian Drug… 
- 
 Joint Factum Submission of CDPC, AIDQ, and HRNA for Supreme Court of Canada Appeal on Good Samaritan LawRead more: Joint Factum Submission of CDPC, AIDQ, and HRNA for Supreme Court of Canada Appeal on Good Samaritan Law[scribd id=778188108 key=key-e0YT0R08tc0MZ7XTjbLi mode=scroll] Download the English Submission. Download the French Submission. Paul Wilson stayed… 
- 
 Submission to the UN Committee on the Elimination of Discrimination Against Women: Review of Canada at 89th SessionRead more: Submission to the UN Committee on the Elimination of Discrimination Against Women: Review of Canada at 89th SessionIn collaboration with HIV Legal Network, CDPC made a submission to the 89th session of… 
- 
 Submission to the Canada Gazette, Part I, Volume 158, Number 22: Controlled Substances RegulationsRead more: Submission to the Canada Gazette, Part I, Volume 158, Number 22: Controlled Substances Regulations[scribd id=755345316 key=key-qIf235IJnvRkIHlLW4K3 mode=scroll] Download PDF On June 1, 2024, Health Canada published a Regulatory… 
- 
 67th Session of the Commission on Narcotic Drugs: Decriminalization as a Public Health and Human Rights Approach to Drug PolicyRead more: 67th Session of the Commission on Narcotic Drugs: Decriminalization as a Public Health and Human Rights Approach to Drug PolicyAt the recent 67th Session of the Commission on Narcotic Drugs, the Canadian Drug Policy… 
- 
 Submission to the HESA Committee Study on “Opioid Epidemic and Toxic Drug Crisis in Canada”Read more: Submission to the HESA Committee Study on “Opioid Epidemic and Toxic Drug Crisis in Canada”The Canadian Drug Policy Coalition submitted a brief on January 10, 2024. The submission focused… 
- 
 Submission to Health Canada on a proposal to control the derivatives and analogues of 4-piperidone and its salts under the Controlled Drugs and Substances ActRead more: Submission to Health Canada on a proposal to control the derivatives and analogues of 4-piperidone and its salts under the Controlled Drugs and Substances ActThe Canadian Drug Policy Coalition made a submission that considered the existing legal framework, lessons… 
- 
 “Innovating Beyond Exclusively Medicalized Approaches” Policy Brief and RecommendationsRead more: “Innovating Beyond Exclusively Medicalized Approaches” Policy Brief and RecommendationsThe Canadian Civil Society Advancing Safe Supply Working Group is a coalition of national, provincial,… 
- 
 Submission to the United Nations Office of the High Commissioner on Human Rights’ study on the decriminalization of homelessness and extreme povertyRead more: Submission to the United Nations Office of the High Commissioner on Human Rights’ study on the decriminalization of homelessness and extreme povertyIn fall 2023, CDPC and Pivot Legal Society made a submission to the United Nations… 
- 
 Human Rights and Decriminalization Done Right: Brief to Standing Committee on Legal and Constitutional Affairs on Bill C-5, An Act to Amend the Criminal Code and the Controlled Drugs and Substances ActRead more: Human Rights and Decriminalization Done Right: Brief to Standing Committee on Legal and Constitutional Affairs on Bill C-5, An Act to Amend the Criminal Code and the Controlled Drugs and Substances ActOn October 19 2022, CDPC was invited to participate in a study on Bill C-5,… 
Support Our Work
Our publications are available to all at no cost. Please consider becoming a supporter and help make important research and ideas available to everyone.
